Furthermore, our in vitro study demonstrated that silencing APOC1 significantly reduced proliferation, clonality, migration and invasion of PCa cells, indicating that APOC1 could be a therapeutic target for PCa with bone metastasis; however, further research is required to elucidate the specific mechanisms involved. This evidence concerns the gene APOC1 and posterior cortical atrophy.